Literature DB >> 11696570

Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?

J D Licht1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11696570      PMCID： PMC209452          DOI： 10.1172/JCI14343

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

Review 1.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

Review 2.  Transcription of eukaryotic protein-coding genes.

Authors:  T I Lee; R A Young
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

5.  Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia.

Authors:  L Z He; T Tolentino; P Grayson; S Zhong; R P Warrell; R A Rifkind; P A Marks; V M Richon; P P Pandolfi
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid.

Authors:  K Kitamura; S Hoshi; M Koike; H Kiyoi; H Saito; T Naoe
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

7.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

Authors:  V M Richon; T W Sandhoff; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Rb targets histone H3 methylation and HP1 to promoters.

Authors:  S J Nielsen; R Schneider; U M Bauer; A J Bannister; A Morrison; D O'Carroll; R Firestein; M Cleary; T Jenuwein; R E Herrera; T Kouzarides
Journal:  Nature       Date:  2001-08-02       Impact factor: 49.962

9.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.

Authors:  M R Rountree; K E Bachman; S B Baylin
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

10.  Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

Authors:  M Liu; M H Lee; M Cohen; M Bommakanti; L P Freedman
Journal:  Genes Dev       Date:  1996-01-15       Impact factor: 11.361
View more
  2 in total

1.  Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.

Authors:  Jihui Qiu; Ying Huang; Guoqiang Chen; Zhu Chen; David J Tweardy; Shuo Dong
Journal:  Mol Biol Cell       Date:  2007-08-01       Impact factor: 4.138

Review 2.  Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?

Authors:  Kyung-Hyun Kim; Kwan-Kyu Park
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.